The brand name xarelto owned by the company named as Bayer in order to market the drug Rivaroxaban. It is a kind of Novel Oral Anticoagulant (NOAC) usually sold in the United States of America. It has been released in the year of 2008 and during this time it has been approved by the organization the US Food and Drugs Administration (FDA) as a kind of blood thinner. The way of working of this drug involves the use of chemical reaction to elongate the process of blood clotting in the human body.
Considerable side effects
This drug initially is used in the treatment of pulmonary embolism and also used it reduce the risk of stroke in the patients having non-valvular atrial fibrillation. It is also used as a famous blood thinner available in the market. But unfortunately it does not possess a proper antidote and this increases the risk of usage of this medicine. For this reason of not having a proper antidote the organization of FDA has labeled this drug with many more contradictions and effects. One of it includes the risk of epidural hematoma, which may sometimes lead to permanent paralysis to the patients who will receive an anesthesia.
Because of not having an antidote the users need to face many xarelto side effects including high internal bleeding even if there is a minor mistake in the administration of this drug. Because of this property this drug is considered as one of the high alert medications and may sometimes cause serious loss of blood in the patients.